These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16182442)

  • 1. Oncogenic action of phospholipase A2 in prostate cancer.
    Dong Q; Patel M; Scott KF; Graham GG; Russell PJ; Sved P
    Cancer Lett; 2006 Aug; 240(1):9-16. PubMed ID: 16182442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic action of secreted phospholipase A2 in prostate cancer.
    Sved P; Scott KF; McLeod D; King NJ; Singh J; Tsatralis T; Nikolov B; Boulas J; Nallan L; Gelb MH; Sajinovic M; Graham GG; Russell PJ; Dong Q
    Cancer Res; 2004 Oct; 64(19):6934-40. PubMed ID: 15466184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
    Attiga FA; Fernandez PM; Weeraratna AT; Manyak MJ; Patierno SR
    Cancer Res; 2000 Aug; 60(16):4629-37. PubMed ID: 10969817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease in expression or activity of cytosolic phospholipase A2alpha increases cyclooxygenase-1 action: A cross-talk between key enzymes in arachidonic acid pathway in prostate cancer cells.
    Niknami M; Vignarajan S; Yao M; Hua S; Witting PK; Kita Y; Shimizu T; Sved P; Patel MI; Dong Q
    Biochim Biophys Acta; 2010 Jul; 1801(7):731-7. PubMed ID: 20227521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytosolic phospholipase A2-alpha and cyclooxygenase-2 localize to intracellular membranes of EA.hy.926 endothelial cells that are distinct from the endoplasmic reticulum and the Golgi apparatus.
    Grewal S; Herbert SP; Ponnambalam S; Walker JH
    FEBS J; 2005 Mar; 272(5):1278-90. PubMed ID: 15720401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging roles for phospholipase A2 enzymes in cancer.
    Scott KF; Sajinovic M; Hein J; Nixdorf S; Galettis P; Liauw W; de Souza P; Dong Q; Graham GG; Russell PJ
    Biochimie; 2010 Jun; 92(6):601-10. PubMed ID: 20362028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors.
    Matsuyama M; Yoshimura R; Mitsuhashi M; Hase T; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
    Int J Oncol; 2004 Apr; 24(4):821-7. PubMed ID: 15010818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secreted phospholipase A2 enzymes as therapeutic targets.
    Scott KF; Graham GG; Bryant KJ
    Expert Opin Ther Targets; 2003 Jun; 7(3):427-40. PubMed ID: 12783578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipase A2 as targets for anti-cancer drugs.
    Cummings BS
    Biochem Pharmacol; 2007 Oct; 74(7):949-59. PubMed ID: 17531957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arachidonic acid, an omega-6 fatty acid, induces cytoplasmic phospholipase A2 in prostate carcinoma cells.
    Hughes-Fulford M; Tjandrawinata RR; Li CF; Sayyah S
    Carcinogenesis; 2005 Sep; 26(9):1520-6. PubMed ID: 15878913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of cyclooxygenase-2 by secretory phospholipases A2 in nerve growth factor-stimulated rat serosal mast cells is facilitated by interaction with fibroblasts and mediated by a mechanism independent of their enzymatic functions.
    Tada K; Murakami M; Kambe T; Kudo I
    J Immunol; 1998 Nov; 161(9):5008-15. PubMed ID: 9794438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade.
    Graff JR; Konicek BW; Deddens JA; Chedid M; Hurst BM; Colligan B; Neubauer BL; Carter HW; Carter JH
    Clin Cancer Res; 2001 Dec; 7(12):3857-61. PubMed ID: 11751475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Labour is associated with increased expression of type-IIA secretory phospholipase A2 but not type-IV cytosolic phospholipase A2 in human myometrium.
    Slater DM; Astle S; Bennett PR; Thornton S
    Mol Hum Reprod; 2004 Nov; 10(11):799-805. PubMed ID: 15361552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of secretory group IIa and V phospholipase A2 and cytosolic group IValpha phospholipase A2 in chondrocytes from patients with rheumatoid arthritis.
    Leistad L; Feuerherm AJ; Ostensen M; Faxvaag A; Johansen B
    Clin Chem Lab Med; 2004; 42(6):602-10. PubMed ID: 15259375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration.
    Liu JW; Shen JJ; Tanzillo-Swarts A; Bhatia B; Maldonado CM; Person MD; Lau SS; Tang DG
    Oncogene; 2003 Mar; 22(10):1475-85. PubMed ID: 12629510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.
    Shappell SB; Olson SJ; Hannah SE; Manning S; Roberts RL; Masumori N; Jisaka M; Boeglin WE; Vader V; Dave DS; Shook MF; Thomas TZ; Funk CD; Brash AR; Matusik RJ
    Cancer Res; 2003 May; 63(9):2256-67. PubMed ID: 12727848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of arachidonic acid metabolism and EGF receptor in neurotensin-induced prostate cancer PC3 cell growth.
    Hassan S; Carraway RE
    Regul Pept; 2006 Jan; 133(1-3):105-14. PubMed ID: 16330112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitfalls in the use of arachidonic acid oxidation products to assign lipoxygenase activity in cancer cells.
    Niknami M; Dong Q; Witting PK
    Free Radic Res; 2009 Oct; 43(10):951-6. PubMed ID: 19680997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytosolic phospholipase A2-alpha: a potential therapeutic target for prostate cancer.
    Patel MI; Singh J; Niknami M; Kurek C; Yao M; Lu S; Maclean F; King NJ; Gelb MH; Scott KF; Russell PJ; Boulas J; Dong Q
    Clin Cancer Res; 2008 Dec; 14(24):8070-9. PubMed ID: 19088022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma.
    Jiang J; Neubauer BL; Graff JR; Chedid M; Thomas JE; Roehm NW; Zhang S; Eckert GJ; Koch MO; Eble JN; Cheng L
    Am J Pathol; 2002 Feb; 160(2):667-71. PubMed ID: 11839587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.